Fewer drugs listed on public drug plans after introduction of Canada’s common drug review but faster listing for coverage

The number of drugs covered by public drug plans decreased substantially after Canada’s Common Drug Review was introduced in 2003, and new drugs were listed more quickly in several of the smaller provinces, a new study finds.